• LAST PRICE
    0.0100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ 0
  • Ask / Lots
    ---/ 0
  • Open / Previous Close
    0.0000 / 0.0100
  • Day Range
    ---
  • 52 Week Range
    Low 0.0050
    High 0.0350
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaPSYB.H
PsyBio Therapeutics Corp
838.7K
-0.3x
---
CanadaABRT
Albert Labs International Corp
1.1M
-0.3x
---
CanadaZENI.P
Zenith Capital Corp
775.5K
-0.7x
---
CanadaMBI.H
Many Bright Ideas Technologies Inc
914.9K
-13.1x
---
CanadaCLAS.H
Claritas Pharmaceuticals Inc
952.5K
-0.3x
---
CanadaTEQ
Terranueva Corp
949.9K
-1.6x
---
As of 2024-05-20

Company Information

PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged in research and development for occurring psychoactive tryptamines, which is originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines, and combinations thereof. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.

Contact Information

Headquarters
4400 Sample Road; Suite138COCONUT CREEK, FL, United States 33073
Phone
513-449-9585
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Evan Levine
Chief Financial Officer, Corporate Secretary, Director
Noah Davis
Chief Medical Officer
Michael Spigarelli
Chief Legal Officer, Director
Ross Carrmel
Independent Director
Nitin Kaushal

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$838.7K
Revenue (TTM)
$0.00
Shares Outstanding
83.9M
PsyBio Therapeutics Corp does not pay a dividend.
Beta
---
EPS
$-0.03
Book Value
$-0.02
P/E Ratio
-0.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.